Terms: = Leukemia AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
249 results:
1. Validation of genes for H-ARS severity prediction in leukemia patients - interspecies comparison, challenges, and promises.
Schwanke D; Valente M; Ostheim P; Schüle S; Bobyk L; Drouet M; Riccobono D; Magné N; Daguenet E; Stewart SJ; Muhtadi R; Port M; Abend M
Int J Radiat Biol; 2024; 100(4):527-540. PubMed ID: 38227483
[TBL] [Abstract] [Full Text] [Related]
2. The biological role of lncRNAs in the acute lymphocytic leukemia: An updated review.
Ghahramani Almanghadim H; Karimi B; Poursalehi N; Sanavandi M; Atefi Pourfardin S; Ghaedi K
Gene; 2024 Mar; 898():148074. PubMed ID: 38104953
[TBL] [Abstract] [Full Text] [Related]
3. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease.
Rubino V; Carriero F; Palatucci AT; Giovazzino A; Leone S; Nicolella V; Calabrò M; Montanaro R; Brancaleone V; Pane F; Chiurazzi F; Ruggiero G; Terrazzano G
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298547
[TBL] [Abstract] [Full Text] [Related]
4. Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.
Kumar A; Taghi Khani A; Duault C; Aramburo S; Sanchez Ortiz A; Lee SJ; Chan A; McDonald T; Huang M; Lacayo NJ; Sakamoto KM; Yu J; Hurtz C; Carroll M; Tasian SK; Ghoda L; Marcucci G; Gu Z; Rosen ST; Armenian S; Izraeli S; Chen CW; Caligiuri MA; Forman SJ; Maecker HT; Swaminathan S
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217248
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer.
Ortiz-Barahona V; Soler M; Davalos V; García-Prieto CA; Janin M; Setien F; Fernández-Rebollo I; Bech-Serra JJ; De La Torre C; Guil S; Villanueva A; Zhang PH; Yang L; Guarnacci M; Schumann U; Preiss T; Balaseviciute U; Montal R; Llovet JM; Esteller M
Mol Cancer; 2023 May; 22(1):83. PubMed ID: 37173708
[TBL] [Abstract] [Full Text] [Related]
6. SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells.
Wen L; Wang XZ; Qiu Y; Zhou YP; Zhang QY; Cheng S; Sun JY; Jiang XJ; Rayner S; Britt WJ; Chen J; Hu F; Li FC; Luo MH; Cheng H
PLoS Pathog; 2023 Apr; 19(4):e1011316. PubMed ID: 37058447
[TBL] [Abstract] [Full Text] [Related]
7. Serpin B9 controls tumor cell killing by CAR T cells.
Kimman T; Slomp A; Martens A; Grabherr S; Li S; van Diest E; Meeldijk J; Kuball J; Minnema MC; Eldering E; Bovenschen N; Sebestyén Z; Peperzak V
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36931661
[TBL] [Abstract] [Full Text] [Related]
8. Differential effects of recombinant human thrombopoietin on clinical outcomes in CD7-positive and CD7-negative acute myeloid leukaemia.
Sun X; Bai Y; Li M; Li W; Wang H; Xiao M; Dou L; Song J; Niu J; Xiao X; Chen Y; Sun K
Leuk Res; 2023 May; 128():107034. PubMed ID: 36906940
[TBL] [Abstract] [Full Text] [Related]
9. Mechanism of Action of Decitabine in the Treatment of Acute Myeloid leukemia by Regulating LINC00599.
Du F; Jin T; Wang L
Anal Cell Pathol (Amst); 2023; 2023():2951519. PubMed ID: 36874552
[TBL] [Abstract] [Full Text] [Related]
10. Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma.
Luanpitpong S; Janan M; Yosudjai J; Poohadsuan J; Chanvorachote P; Issaragrisil S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430955
[TBL] [Abstract] [Full Text] [Related]
11. The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression.
Yao CY; Lin CC; Wang YH; Hsu CL; Kao CJ; Hou HA; Chou WC; Tien HF
J Formos Med Assoc; 2023 Jul; 122(7):636-647. PubMed ID: 36428148
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic and immunophenotypic features in dogs with presumptive large granular lymphocyte leukaemia.
Jaensch SM; Hayward DA; Boyd SP
Aust Vet J; 2022 Nov; 100(11):527-532. PubMed ID: 36328541
[TBL] [Abstract] [Full Text] [Related]
13. Revealing molecular architecture of FLT3 internal tandem duplication: Development and clinical validation of a web-based application to generate accurate nomenclature.
Ding Y; Smith GH; Deeb K; Schneider T; Campbell A; Zhang L
Int J Lab Hematol; 2022 Oct; 44(5):918-927. PubMed ID: 35795913
[TBL] [Abstract] [Full Text] [Related]
14. Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
[TBL] [Abstract] [Full Text] [Related]
15. RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.
Masuda T; Maeda S; Shimada S; Sakuramoto N; Morita K; Koyama A; Suzuki K; Mitsuda Y; Matsuo H; Kubota H; Kato I; Tanaka K; Takita J; Hirata M; Kataoka TR; Nakahata T; Adachi S; Hirai H; Mizuta S; Naka K; Imai Y; Kimura S; Sugiyama H; Kamikubo Y
Cancer Sci; 2022 Feb; 113(2):529-539. PubMed ID: 34902205
[TBL] [Abstract] [Full Text] [Related]
16. Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and outcomes.
Rivas MA; Durmaz C; Kloetgen A; Chin CR; Chen Z; Bhinder B; Koren A; Viny AD; Scharer CD; Boss JM; Elemento O; Mason CE; Melnick AM
Front Immunol; 2021; 12():688493. PubMed ID: 34621263
[TBL] [Abstract] [Full Text] [Related]
17. Homogeneously high expression of CD32b makes it a potential target for CAR-T therapy for chronic lymphocytic leukemia.
Wang G; Sun X; Zuo S; Li C; Niu Q; Xia Y; Meng Y; Liu M; Fang Z; Yang X; Jiang Y; Wang S; Cui H; Huang H; Jiang E; Zhou D; Deng Q; Pan J; Feng X
J Hematol Oncol; 2021 Sep; 14(1):149. PubMed ID: 34530888
[TBL] [Abstract] [Full Text] [Related]
18. Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance.
Loriot Y; Marabelle A; Guégan JP; Danlos FX; Besse B; Chaput N; Massard C; Planchard D; Robert C; Even C; Khettab M; Tselikas L; Friboulet L; André F; Nafia I; Le Loarer F; Soria JC; Bessede A; Italiano A
Ann Oncol; 2021 Nov; 32(11):1381-1390. PubMed ID: 34416362
[TBL] [Abstract] [Full Text] [Related]
19. A novel fusion protein TBLR1-RARα acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies.
Li S; Yang X; Liu S; Chen Y; Xing H; Tang K; Tian Z; Xu Y; Rao Q; Wang M; Wang J
Cell Death Dis; 2021 Jun; 12(6):607. PubMed ID: 34117212
[TBL] [Abstract] [Full Text] [Related]
20. Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression.
Omori T; Tazawa H; Yamakawa Y; Osaki S; Hasei J; Sugiu K; Komatsubara T; Fujiwara T; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
PLoS One; 2021; 16(4):e0250643. PubMed ID: 33886686
[TBL] [Abstract] [Full Text] [Related]
[Next]
